Myriad Genetics names Vishal Sikri as EVP of Commercial, effective September 16, 2026
Sikri steps up from SVP of Product to succeed Brian Donnelly, who is leaving the company on September 21, 2026.
SEC filing
Latest
2 stories
Wednesday, September 16
Thursday, July 30
Myriad Genetics reports Q2 2026 revenue decline, launches efficiency initiative, cuts guidance
Myriad Genetics posted an 11% year-over-year revenue drop to $190.7 million and revised its full-year 2026 guidance while advancing several diagnostic programs.
SEC filing